Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya Acute Myocardial Infarction Study.
Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, Ishii H, Kondo T, Murohara T; Nagoya Acute Myocardial Infarction Study (NAMIS) Group. Matsudaira K, et al. Among authors: morita y. Circ J. 2012;76(6):1509-16. doi: 10.1253/circj.cj-11-1127. Epub 2012 Mar 27. Circ J. 2012. PMID: 22452999 Free article.
Rho-kinase modulates the function of STEF, a Rac GEF, through its phosphorylation.
Takefuji M, Mori K, Morita Y, Arimura N, Nishimura T, Nakayama M, Hoshino M, Iwamatsu A, Murohara T, Kaibuchi K, Amano M. Takefuji M, et al. Among authors: morita y. Biochem Biophys Res Commun. 2007 Apr 13;355(3):788-94. doi: 10.1016/j.bbrc.2007.02.028. Epub 2007 Feb 14. Biochem Biophys Res Commun. 2007. PMID: 17320046
Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging.
Morishima I, Sone T, Tsuboi H, Mukawa H, Uesugi M, Morikawa S, Takagi K, Niwa T, Morita Y, Murakami R, Numaguchi Y, Murohara T, Okumura K. Morishima I, et al. Among authors: morita y. J Nucl Cardiol. 2008 Sep-Oct;15(5):631-7. doi: 10.1016/j.nuclcard.2008.03.009. Epub 2008 Jun 12. J Nucl Cardiol. 2008. PMID: 18761265 Clinical Trial.
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
Yamada S, Ishii H, Takahashi H, Aoyama T, Morita Y, Kasuga H, Kimura K, Ito Y, Takahashi R, Toriyama T, Yasuda Y, Hayashi M, Kamiya H, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T. Yamada S, et al. Among authors: morita y. Clin J Am Soc Nephrol. 2010 Oct;5(10):1793-8. doi: 10.2215/CJN.00050110. Epub 2010 Jul 1. Clin J Am Soc Nephrol. 2010. PMID: 20595691 Free PMC article.
Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men.
Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Yamashita K, Maeda K, Muramatsu T, Shintani S, Matsushita K, Murohara T. Kondo T, et al. Among authors: morita y. Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):574-80. doi: 10.1177/1741826710389529. Epub 2011 Feb 14. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 21450628
3,177 results